Drug Trial Radar · NCT01052025
Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
Last checked: Nov 20, 2026Latest source record: Jan 20, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Aug 2009
Primary completion
Mar 2010
Study completion Apr 2010
Sponsor
- Lead sponsor
- Srinakharinwirot UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ministry of Health, Thailand
- First posted
- Jan 20, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The incidence rate of type 2 diabetes in Thai populations is high and increasing every year. Cardiovascular disease is the main complication of this disease, which has been defined as an important cause of death among Diabetic patients. This disease is now becoming a major health problem and causes a great economic loss to the country. Evidence shows that Curcumin, Thai herbal medicine, has the effectiveness of prevention and delay of type 2 diabetes. However, there is no scientific study that aims to prove the efficacy of this herb particularly for prevention and delay the disease in Patients with impaired glucose tolerance (pre-diabetes) and insulin resistance.
Conditions
- Type 2 Diabetes
- Pre-diabetes
- Insulin Resistance
- Cardiovascular Risk
Interventions
CurcuminDrug
curcumin capsule contains 250 mg curcuminoiods, 3 capsules per time, 2 times a day before meal for 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- To examine the efficacy of curcumin on the delay of degenerative beta-cells in pancrease for protection of Type 2 Diabetes in patients with impaired glucose tolerance (Pre-diabetes)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
HRH Princess Maha Chakri Sirindhorn Medical Center
Ongkarak, Nakornnayok, Thailand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.